Latest Biosimilar Stories
REDWOOD CITY, Calif., Sept.
An Alliance Of 5 Companies Experienced In Biosimilars Development MANNHEIN, Germany, Sept.
SAN DIEGO, Sept. 19, 2014 /PRNewswire/ -- Pfenex Inc.
Improved Efficacy and Lower List Price than the Anti-TNFs Will Be the Key Drivers for Prescribing of Emerging Therapies, According to Findings from Decision Resources Group BURLINGTON, Mass.,
The Imminent Entry of Biosimilars Will Constrain Sales of Branded Biologics and Premium-Priced Emerging Agents, According to Findings from Decision Resources Group BURLINGTON, Mass., Sept.
Regulators, pharmaceutical, biotechnology and medical device industry leaders, innovators, thought leaders and other regulatory stakeholders will participate in the Regulatory Affairs Professionals
DALLAS, September 10, 2014 /PRNewswire/ -- According to the new market research report "Human Microbiome Market by Disease (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea,
- a meat pie that is usually eaten at Christmas in Quebec